Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 6 of 7 for:    C3Po

Carolina-ColoWrap® in Colonoscopy Performance and Outcomes Study (C3PO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02025504
Recruitment Status : Completed
First Posted : January 1, 2014
Last Update Posted : April 3, 2015
Sponsor:
Collaborator:
University of North Carolina, Chapel Hill
Information provided by (Responsible Party):
ColoWrap, LLC

Brief Summary:
Colonoscopy is the gold-standard for colorectal cancer screening in the US. However, complete colonoscopy can be a challenging technical procedure, even for expert gastroenterologists due to variations in patient anatomy, tortuous colons, and looping of the endoscope. Such obstacles can prolong colonoscopy, lead to complications, decrease polyp detection, and impact patient experience and tolerance. The investigators propose to evaluate the efficacy of a new non-invasive abdominal binder (ColoWrap®) in improving the performance and tolerance of colonoscopy by way of a randomized, blinded clinical trial. Eligible participants undergoing colonoscopy at University of North Carolina Hospitals (UNCH) will be recruited for the study and randomized to either the ColoWrap intervention or sham arm. Colonoscopy will be performed per usual operating procedures. The primary outcome will be time to distal extent (cecal intubation time). Secondary outcomes include colonoscopy completion rate, use of ancillary maneuvers, medication usage, procedural difficulty, patient comfort, and operator and assistant fatigue and pain. Efficacy will be assessed on the basis of pairwise comparisons between groups with respect to primary and secondary outcomes.

Condition or disease Intervention/treatment Phase
Performance and Tolerance of Colonoscopy Device: ColoWrap Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 350 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Care Provider)
Primary Purpose: Prevention
Official Title: Efficacy of ColoWrap® Abdominal Binder in Improving Performance and Tolerance of Colonoscopy: a Randomized, Sham-Controlled, Blinded Clinical Trial
Study Start Date : April 2014
Actual Primary Completion Date : March 2015
Actual Study Completion Date : March 2015

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Colonoscopy

Arm Intervention/treatment
Experimental: ColoWrap Intervention Group
Patients randomized to ColoWrap Intervention Group will have the ColoWrap abdominal binder secured firmly around their lower abdomen just prior to colonoscopy.
Device: ColoWrap
ColoWrap is an abdominal binder intended as an accessory to facilitate colonoscopy.
Other Names:
  • ColoWrap abdominal binder
  • ColoWrap colonoscopy binder
  • ColoWrap device
  • ColoWrap binder

Sham Comparator: Sham Group
Sham Group will also have a ColoWrap binder placed around their lower abdomen, but it will be placed loosely so no appreciable lower abdominal pressure is generated by the device.
Device: ColoWrap
ColoWrap is an abdominal binder intended as an accessory to facilitate colonoscopy.
Other Names:
  • ColoWrap abdominal binder
  • ColoWrap colonoscopy binder
  • ColoWrap device
  • ColoWrap binder




Primary Outcome Measures :
  1. Mean colonoscopic insertion time [ Time Frame: During colonoscopy, from insertion of scope into rectum to point in time when base of cecum is identified ]
    Colonoscopic insertion time will be defined as the time from insertion of the colonoscope into the rectum to identification of the base of the cecum


Secondary Outcome Measures :
  1. Frequency of use of ancillary maneuvers [ Time Frame: During colonoscopy, from insertion of scope into rectum to point in time when base of cecum is identified ]
    Binary data indicating individually whether abdominal pressure or patient position change was used during the insertion phase of the procedure will be recorded.

  2. Frequency of prolonged, difficult cases [ Time Frame: During colonoscopy, from time point of insertion of scope into rectum to point in time when scope is removed from rectum ]
    The frequency of prolonged, difficult cases. Procedures in which the insertion phase is greater than 20 min will be recorded and indicated as such.

  3. Drug and Dosage Required to Complete Procedure [ Time Frame: During colonoscopy, from time point of insertion of scope into rectum to point in time when scope is removed from rectum ]
    Drug and dosage amount required by patient to complete colonoscopy.

  4. Colonoscopy Completion Rate [ Time Frame: During colonoscopy, from time point of insertion of scope into rectum to point in time when scope is removed from rectum ]
    Colonoscopy completion rate. Dichotomous outcome indicating if the procedure was incomplete or complete.

  5. Time to patient discharge [ Time Frame: From time point in which scope is removed from patient's rectum following a colonoscopy until the time the patient is discharged from the facility ]
    Time to discharge, defined as the time from withdrawal of the colonoscope to patient discharge from the endoscopy unit.

  6. Operator perception of patient discomfort [ Time Frame: During colonoscopy, from insertion of scope into rectum to point in time when base of cecum is identified ]
    Immediately following completion of procedure, ColoWrap study assistant will obtain operator perception of patient discomfort during procedure according to the Gloucester score

  7. Patient Pain, Bloating, and Satisfaction at Discharge [ Time Frame: At single time point occurring after the colonoscopy, just prior to the patient being discharged from facility ]
    The ColoWrap study assistant will interview patient just prior to discharge and obtain responses for pain and bloating according to 10-point visual analog scales, and global satisfaction according to a 5-point scale.

  8. Operator's Assessment of Procedural Difficultly [ Time Frame: During colonoscopy, from insertion of scope into rectum to point in time when base of cecum is identified ]
    Immediately following completion of procedure, the study assistant will obtain the operator's assessment of procedural difficulty and level of physical fatigue according to 5-point scales.

  9. Assistant/Technician's Assessment of Musculoskeletal Pain Following Procedure [ Time Frame: During colonoscopy, from insertion of scope into rectum to point in time when base of cecum is identified ]
    The study assistant will ask the endoscopy technician if they experienced pain during the procedure in any of the following four anatomical sites: lower back, upper back, neck, or upper extremities (right and left shoulder, arm, wrist, hand, fingers). This frequency data will be dichotomous.


Other Outcome Measures:
  1. Patient Assessment of Intra-Procedural Pain [ Time Frame: During colonoscopy, from insertion of scope into rectum to point in time when base of cecum is identified ]
    For patients undergoing colonoscopy with conscious sedation, the study assistant will also obtain a response for intra-procedural pain, using a validated measure of procedural comfort.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   40 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Male and female adults between the ages of 40 - 80
  • Undergoing a colonoscopy at any of the study locations for:

    i. CRC screening (first colonoscopy or 10 year follow up of negative exam). ii. Surveillance (prior colonoscopy with polyps). iii. Diagnostic colonoscopy performed to evaluate symptoms such as abdominal pain or rectal bleeding.

  • Participants must have completed the full prescribed colonoscopy purgative preparation prior to their procedure, and describe adequate cleansing.
  • For the purposes of informed consent, participants must be able to understand and read English.

Exclusion Criteria:

  • Inability to provide informed consent
  • Active or suspected pregnancy
  • Patients referred due to incomplete colonoscopy or for removal of difficult polyps
  • History of problems with sedation or anesthesia -. Participants electing to be unsedated for colonoscopy
  • Patients undergoing multiple procedures (e.g. upper and lower endoscopy)
  • Previous colon resection surgery
  • Patients with known or suspected diagnosis of inflammatory bowel disease (ulcerative colitis or Crohn's disease)
  • Patients with a history of colorectal cancer or other intra-abdominal malignancy.
  • Patients with open or recent wounds or skin rash on the anterior abdominal wall.
  • History of cirrhosis or ascites
  • Known ventral or umbilical hernia
  • Patients who are medically unstable(American Society of Anesthesiology Class III or above).

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02025504


Locations
Layout table for location information
United States, North Carolina
UNC Hospitals
Chapel Hill, North Carolina, United States, 27514
UNC Meadowmont Endoscopy Center
Chapel Hill, North Carolina, United States, 27517
UNC Hillsborough Endoscopy Center
Hillsborough, North Carolina, United States, 27278
Sponsors and Collaborators
ColoWrap, LLC
University of North Carolina, Chapel Hill
Investigators
Layout table for investigator information
Principal Investigator: Seth D Crockett, MD, MPH Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, NC
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: ColoWrap, LLC
ClinicalTrials.gov Identifier: NCT02025504    
Other Study ID Numbers: ColoWrap-002
First Posted: January 1, 2014    Key Record Dates
Last Update Posted: April 3, 2015
Last Verified: March 2015
Keywords provided by ColoWrap, LLC:
Colonoscopy, Looping, Sigmoid Looping, ColoWrap, Binder, Patient Satisfaction